8156489

Source:http://linkedlifedata.com/resource/pubmed/id/8156489

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021083, umls-concept:C0025202, umls-concept:C0030705, umls-concept:C0085278, umls-concept:C0332281
pubmed:issue	6
pubmed:dateCreated	1994-5-13
pubmed:abstractText	Immunotherapy for patients with cancer is associated with severe side effects, including the possible induction of autoantibodies. The latter was proven for antithyroid microsomal and antithyroglobulin antibodies.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/8156489-7743490
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antinuclear, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antiphospholipid, http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies, http://linkedlifedata.com/resource/pubmed/chemical/Cardiolipins, http://linkedlifedata.com/resource/pubmed/chemical/Carmustine, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Dacarbazine, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0008-543X
pubmed:author	pubmed-author:BeckerJ CJC, pubmed-author:BröckerE BEB, pubmed-author:KlingertSS, pubmed-author:WinklerBB
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	73
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1621-4
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:8156489-Adult, pubmed-meshheading:8156489-Aged, pubmed-meshheading:8156489-Antibodies, Antinuclear, pubmed-meshheading:8156489-Antibodies, Antiphospholipid, pubmed-meshheading:8156489-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:8156489-Antiphospholipid Syndrome, pubmed-meshheading:8156489-Autoantibodies, pubmed-meshheading:8156489-Cardiolipins, pubmed-meshheading:8156489-Carmustine, pubmed-meshheading:8156489-Chemotherapy, Adjuvant, pubmed-meshheading:8156489-Cisplatin, pubmed-meshheading:8156489-Dacarbazine, pubmed-meshheading:8156489-Female, pubmed-meshheading:8156489-Humans, pubmed-meshheading:8156489-Immunoglobulin G, pubmed-meshheading:8156489-Immunotherapy, pubmed-meshheading:8156489-Interferon-alpha, pubmed-meshheading:8156489-Interleukin-2, pubmed-meshheading:8156489-Male, pubmed-meshheading:8156489-Melanoma, pubmed-meshheading:8156489-Middle Aged, pubmed-meshheading:8156489-Recombinant Proteins, pubmed-meshheading:8156489-Tamoxifen, pubmed-meshheading:8156489-Thromboembolism
pubmed:year	1994
pubmed:articleTitle	Antiphospholipid syndrome associated with immunotherapy for patients with melanoma.
pubmed:affiliation	Department of Dermatology, University of Würzburg, Germany.
pubmed:publicationType	Journal Article